Abstract:Background-Oxidative stress, an excessive production of reactive oxygen species (ROS) outstripping antioxidant defense mechanisms, occurs in cardiovascular pathologies, including hypertension. In the present study, we used biochemical, physiological, and pharmacological approaches to explore the role of derangements of catecholamines, ROS, and the endothelium-derived relaxing factor nitric oxide (NO center dot) in the development of a hyperadrenergic model of hereditary hypertension: targeted ablation (knockout [KO]) of chromogranin A (Chga) in the mouse.Methods and Results-Homozygous (-/-) Chga gene knockout (KO) mice were compared with wild-type (WT, +/+) control mice. In the KO mouse, elevations of systolic and diastolic blood pressure were accompanied by not only elevated catecholamine (norepinephrine and epinephrine) concentrations but also increased ROS (H2O2) and isoprostane (an index of lipid peroxidation), as well as depletion of NO center dot. Renal transcript analyses implicated changes in Nox1/2, Xo/Xdh, and Sod1,2 mRNAs in ROS elevation by the KO state. KO alterations in blood pressure, catecholamines, H2O2, isoprostane, and NO center dot could be abrogated or even normalized (rescued) by either sympathetic outflow inhibition (with clonidine) or NADPH oxidase inhibition (with apocynin). In cultured renal podocytes, H2O2 production was substantially augmented by epinephrine (probably through beta 2-adrenergic receptors) and modestly diminished by norepinephrine (probably through alpha(1)-adrenergic receptors).Conclusions-ROS appear to play a necessary role in the development of hyperadrenergic hypertension in this model, in a process mechanistically linking elevated blood pressure with catecholamine excess, renal transcriptional responses, ROS elevation, lipid peroxidation, and NO center dot depletion. Some of the changes appear to be dependent on transcription, whereas others are immediate. The cycle could be disrupted by inhibition of either sympathetic outflow or NADPH oxidase. Because common genetic variation at the human CHGA locus alters BP, the results have implications for antihypertensive treatment as well as prevention of target-organ consequences of the disease. The results document novel pathophysiological links between the adrenergic system and oxidative stress and suggest new strategies to probe the role and actions of ROS within this setting. (Circ Cardiovasc Genet. 2010;3:414-425.)

Effect of chromogranin A on central autonomic control of blood pressure

Brain Microglial Cytokines in Neurogenic Hypertension

The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1

Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo

Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation

Role of Reactive Oxygen Species in Hyperadrenergic Hypertension Biochemical, Physiological, and Pharmacological Evidence from Targeted Ablation of the Chromogranin A (chga) Gene

Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation

Impact of ginsenoside-Rg3 on catecholamine secretion in the perfused model of the rat adrenal medullae

Adrenomedullin microinjection into the area postrema increases blood pressure.

The Effect of A2AReceptor Antagonist on Microglial Activation in Experimental Glaucoma

Effects of Angiotensin II on Release of CRH and AVP from Hypothalamus During Acute Hypoxia.

Molecular Mechanism for Hypertensive Renal Disease

Cardiovascular Effects of Microinjection of Corticoids and Antagonists Into the Rostral Ventrolateral Medulla in Rats

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury

Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

Chromogranin A Polymorphisms Are Associated with Hypertensive Renal Disease.

Effect of Adrenomedullin on the Activity of Barosensitive Neurons in the Rostral Ventrolateral Medulla of Rats

Chromogranin B Protects Human Umbilical Endothelial Cells against Oxidative Stress

Naturally Occurring Human Genetic Variation in the 3′-Untranslated Region of the Secretory Protein Chromogranin A is Associated with Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion

Inflammatory Cytokines in Paraventricular Nucleus Modulate Sympathetic Activity and Cardiac Sympathetic Afferent Reflex in Rats

Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.